- The company combines proprietary imaging hardware, FDA-cleared AI applications, cloud software, radiology services and healthcare IT within an end-to-end platform spanning scan, analysis and interpretation.
- Nanox is expanding its commercial reach through its U.S. commercial activities and collaboration with healthcare organizations.
- First-quarter 2026 revenue increased to $4.3 million from $2.8 million in the prior-year period, with contributions from teleradiology, imaging systems, OEM services, AI, software and Health IT.
- Nanox has secured FDA clearance for Nanox.ARC, Nanox.ARC X and three Nanox.AI medical imaging solutions, while its commercial and clinical activities involve organizations including RadNet, Cedars-Sinai, Corewell Health and Brigham and Women’s Hospital.
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform.
Questions around this news
What does Nano-X Imaging's imaging and healthcare platform include?
The release describes a system that brings together imaging hardware, AI-based analysis, cloud software, remote radiology services, healthcare IT and a marketplace. It presents these elements as supporting the stages from taking a scan through analysis and interpretation, alongside the company's U.S. commercial activities and work with healthcare organizations.
What revenue did Nano-X Imaging report for the first quarter of 2026?
The release reports first-quarter 2026 revenue of $4.3 million, compared with $2.8 million in the same period a year earlier. It attributes revenue to several areas: teleradiology, imaging systems, original equipment manufacturer services, AI, software and healthcare IT.
Which products and medical imaging solutions have received FDA clearance?
The release says the company has obtained FDA clearance for Nanox.ARC and Nanox.ARC X, as well as three of its AI medical imaging solutions. It also names RadNet, Cedars-Sinai, Corewell Health and Brigham and Women’s Hospital among organizations involved in its commercial and clinical activities.
What is teleradiology?
Teleradiology is the transmission of medical images, such as X-rays or CT scans, to radiologists in another location for review and interpretation. It can let healthcare providers access radiology expertise remotely, rather than requiring the interpreting specialist to be at the facility where the images were taken.
What does FDA clearance mean for a medical device?
FDA clearance generally means the U.S. Food and Drug Administration has determined that a medical device can be marketed under an applicable regulatory pathway. Clearance is distinct from FDA approval, which applies to different pathways and typically involves a different level of review.
Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to…
NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
The latest news and updates relating to NNOX are available in the company’s newsroom at https://ibn.fm/NNOX
Corporate Communications
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
[email protected]
At a glance
- Company
- Nano-X Imaging
- Ticker
- NASDAQ: NNOX
Key figures
- First-quarter 2026 revenue
- $4.3 million
- Revenue in the prior-year period
- $2.8 million
Products and programs
SEC filings
- 6-KREPORT OF FOREIGN PRIVATE ISSUER Filed
- 6-KREPORT OF FOREIGN PRIVATE ISSUER Filed
- 4Insider transaction Filed
- 6-KREPORT OF FOREIGN PRIVATE ISSUER Filed
- 424B5PROSPECTUS SUPPLEMENT Filed
- 6-KREPORT OF FOREIGN PRIVATE ISSUER Filed
- 144Notice of proposed sale of securities Filed
- 3Initial statement of insider ownership Filed
- SCHEDULE 13G/ASCHEDULE 13G/A Filed
- 4Insider transaction Filed
- 4Insider transaction Filed
- 4PRIMARY DOCUMENT Filed
- 144Notice of proposed sale of securities Filed
- 4Insider transaction Filed
